Article thumbnail

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

By Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He and Charles M Perou
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3096954
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell
  2. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet
  3. (2008). Ansieau SP, Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One
  4. (2002). AT: Gene expression profiling predicts clinical outcome of breast cancer.
  5. (2010). Badve S: Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat
  6. (2009). Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res
  7. (2006). Cell-type specific gene expression profiles of leukocytes in human peripheral blood.
  8. (2008). Chang JC: Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
  9. (2009). Chang JC: Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA
  10. (1998). Cluster analysis and display of genome-wide expression patterns.
  11. (2004). D: Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res
  12. (1998). DF: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
  13. (2007). Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell
  14. (2009). E: Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell
  15. (2008). Eaves C: Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell
  16. (2008). Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res
  17. (2001). Eystein Lønning P, Børresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA
  18. (2005). Hernandez-Boussard T: Determination of stromal signatures in breast carcinoma. PLoS Biol
  19. (2010). Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res
  20. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med
  21. (2008). Human breast cancer cell lines contain stemlike cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res
  22. (2004). Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res
  23. (2008). JS: Statistical Significance of Clustering for High-Dimension, Low-Sample Size Data.
  24. (2006). L: Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
  25. (2009). Lindeman GJ: Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med
  26. (2006). M: BRCA1 mutation analysis Prat et al.
  27. (2009). Mills GB: Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res
  28. (2009). MM: A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature
  29. (2007). Molecular definition of breast tumor heterogeneity. Cancer Cell
  30. (2000). Molecular portraits of human breast tumours. Nature
  31. (2007). Perou C: EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics
  32. (2004). Perou CM: Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res
  33. (2006). Perou CM: Concordance among gene-expression-based predictors for breast cancer.
  34. (2007). Perou CM: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol
  35. (2010). Perou CM: Mammary development meets cancer genomics. Nat Med 2009, 15:842. doi:10.1186/bcr2635 Cite this article as: Prat et al.: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
  36. (2008). Perou CM: The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas. Breast Cancer Res
  37. (2007). Perou CM: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res
  38. (2008). Peterse JL: Refinement of breast cancer classification by molecular characterization of histological special types.
  39. (1998). Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation
  40. (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
  41. (2003). Prospective identification of tumorigenic breast cancer cells.
  42. (2009). PS: Supervised risk predictor of breast cancer based on intrinsic subtypes.
  43. (2003). RA: DAVID: database for annotation, visualization, and integrated discovery. Genome Biol
  44. (2008). RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell
  45. (2008). RB: The fibromatosis signature defines a robust stromal response in breast carcinoma. Lab Invest
  46. (2006). RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA
  47. (1974). Reeves WJ Jr: Establishment of epithelial cell line MDA-MB-157 from metastatic pleural effusion of human breast carcinoma. In Vitro
  48. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet
  49. (2006). The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics
  50. The R Project for Statistical Computing.
  51. (2006). Tutt AN: BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene
  52. (1977). Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines.
  53. (2009). Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer
  54. (2008). Wicha MS: BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA
  55. (2003). Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev